Cellebrite Raises FY26 Adjusted EBITDA Forecast to $163M–$166M
Cellebrite raised its FY26 adjusted EBITDA forecast to $163 million–$166 million.
Related stories
JX Luxventure First-Half Gross Profit Rises 75% to $7.81 Million
First-half 2026 revenue more than doubled to $68.48 million.
M impact | EARNINGS | Nov 12, 2026, 02:04 PM UTC
Uniti Completes 800GE Trial, Sets 2027 Revenue Guidance
Uniti Group and Nokia completed an 800GE service trial. Uniti gave 2027 revenue guidance of $65 million to $85 million, retired $128 million of its 2030 notes at a 36% discount, an
M impact | EARNINGS | Nov 12, 2026, 02:03 PM UTC
Palomar Reports 47% Q3 Adjusted Net Income Growth, Raises 2026 Outlook
Palomar reported third-quarter adjusted net income growth of 47% year over year and raised its full-year 2026 guidance to $280 million–$285 million.
M impact | EARNINGS | Nov 12, 2026, 02:03 PM UTC
Credit Agricole on FX Risk Index
At -0.8904 (vs -0.8691 last week) our Risk Index has moved a little further into risk-seeking territory but remains just above its 100-day moving average, which has flatlined. The
H impact | EARNINGS | Nov 12, 2026, 02:02 PM UTC
Italian Stocks Retreat
Milan’s FTSE MIB fell 0.4% to around 51,700 on Thursday, halting a three-session advance, as losses in tech, heavyweight financials and utility firms weighed on the index. Tech sha
L impact | EARNINGS | Nov 12, 2026, 01:59 PM UTC
TXT e-solutions reports nine-month adjusted net profit of €28.3 million
M impact | EARNINGS | Nov 12, 2026, 01:55 PM UTC